Nexus Surgical and Medicare Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 105611,
    "name": "Nexus Surgical",
    "stock_name": "Nexus Surgical",
    "full_name": "Nexus Surgical and Medicare Ltd",
    "name_url": "stocks-analysis/nexus-surgical",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "19.50",
    "chg": -0.5,
    "chgp": "-2.5%",
    "dir": -1,
    "prev_price": "20.00",
    "mcapval": "11.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538874,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "India SENSEX",
    "isin": "INE370Q01015",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.02 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/nexus-surgical-105611-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-and-medicare-ltd-hits-new-52-week-high-of-rs25-3987489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NexusSurgicalan_priceRelatedfactors_3987489.png",
        "date": "2026-05-12 10:35:03",
        "description": "Surging to a fresh 52-week high of Rs 25 on 12 May 2026, Nexus Surgical and Medicare Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a bearish backdrop for the Sensex."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 24.51",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-and-medicare-ltd-hits-new-52-week-high-at-rs2451-3985701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NexusSurgicalan_priceRelatedfactors_3985701.png",
        "date": "2026-05-11 13:35:03",
        "description": "With a 62.97% gain over the past year, Nexus Surgical and Medicare Ltd surged to a fresh 52-week high of Rs 24.51 on 11 May 2026, outpacing the Sensex which declined 3.74% over the same period. This milestone caps a five-day winning streak that has propelled the stock 35.04% higher, underscoring a powerful momentum shift despite a broadly weaker market backdrop."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Upgraded to Sell Amid Mixed Technicals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-upgraded-to-sell-amid-mixed-technicals-and-valuation-concerns-3929587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NexusSurgicalan_mojoScore_3929587.png",
        "date": "2026-04-02 08:05:02",
        "description": "Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, driven primarily by changes in its technical outlook despite persistent fundamental challenges. The micro-cap NBFC’s technical indicators have shifted from mildly bullish to sideways, prompting a reassessment of its near-term prospects amid flat financial performance and valuation concerns."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-downgraded-to-strong-sell-amid-technical-and-valuation-concerns-3917644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/NexusSurgicalan_mojoScore_3917644.png",
        "date": "2026-03-26 08:03:35",
        "description": "Nexus Surgical and Medicare Ltd, a micro-cap player in the Non-Banking Financial Company (NBFC) sector, has been downgraded from a Sell to a Strong Sell rating as of 25 March 2026. The revision reflects a deterioration in technical indicators, valuation concerns, and a flat financial trend, despite the company’s historically strong returns over the long term. This comprehensive analysis explores the four key parameters that triggered the rating change: Quality, Valuation, Financial Trend, and Technicals."
      }
    ],
    "total": 10,
    "sid": "105611",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/nexus-surgical-and-medicare-105611"
  },
  "announcements": [
    {
      "caption": "Announcement Under Reg. 30 - Appointment Of Internal Auditors",
      "datetime": "28-May-2026",
      "details": "Appointment of M/s. VMRS & Co. Chartered Accountants as the Internal Auditors of the Company for the F.Y. 2026-27",
      "source": "BSE"
    },
    {
      "caption": "Results - Financial Results For 31-03-2026",
      "datetime": "28-May-2026",
      "details": "Submission of Audited Financial Results for the quarter and year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 28Th May 2026",
      "datetime": "28-May-2026",
      "details": "Submission of Outcome of Board Meeting held on Thursday 28th May 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 25

2026-05-12 10:35:03

Surging to a fresh 52-week high of Rs 25 on 12 May 2026, Nexus Surgical and Medicare Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a bearish backdrop for the Sensex.

Broad-Based Technical Strength Lifts Nexus Surgical and Medicare Ltd to 52-Week High of Rs 24.51

2026-05-11 13:35:03

With a 62.97% gain over the past year, Nexus Surgical and Medicare Ltd surged to a fresh 52-week high of Rs 24.51 on 11 May 2026, outpacing the Sensex which declined 3.74% over the same period. This milestone caps a five-day winning streak that has propelled the stock 35.04% higher, underscoring a powerful momentum shift despite a broadly weaker market backdrop.

Nexus Surgical and Medicare Ltd Upgraded to Sell Amid Mixed Technicals and Valuation Concerns

2026-04-02 08:05:02

Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 April 2026, driven primarily by changes in its technical outlook despite persistent fundamental challenges. The micro-cap NBFC’s technical indicators have shifted from mildly bullish to sideways, prompting a reassessment of its near-term prospects amid flat financial performance and valuation concerns.

Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns

2026-03-26 08:03:35

Nexus Surgical and Medicare Ltd, a micro-cap player in the Non-Banking Financial Company (NBFC) sector, has been downgraded from a Sell to a Strong Sell rating as of 25 March 2026. The revision reflects a deterioration in technical indicators, valuation concerns, and a flat financial trend, despite the company’s historically strong returns over the long term. This comprehensive analysis explores the four key parameters that triggered the rating change: Quality, Valuation, Financial Trend, and Technicals.

View All News